GE HealthCare Technologies Inc. (NASDAQ:GEHC) Wells Fargo 20th Annual Healthcare Conference 2025 September 4, 2025 8:45 AM EDT
Company Participants
James Saccaro – VP & CFO
Carolynne Borders – Chief Investor Relations Officer
Conference Call Participants
Larry Biegelsen – Wells Fargo Securities, LLC, Research Division
Presentation
Larry Biegelsen
Senior Medical Device Equity Research Analyst
Good morning. I’m Larry Biegelsen, the medical device analyst at Wells Fargo. Pleasure to host this fireside chat with management of GE HealthCare. With us, we have Jay Saccaro, the CFO; and Carolynne Borders, Head of Investor Relations. The format is a fireside chat. This 1 has a question, Jay and Carolynne, thanks for being here. If anybody has a question, please raise your hand. Jay and Carolynne, thanks for being here. Thanks for being strong supporters at the Wells Fargo Healthcare Conference. Appreciate it.
James Saccaro
VP & CFO
Yes, absolutely. Larry, thank you for the invitation as always. And then to those in attendance, thanks for joining us today. We appreciate your interest in our company.
Question-and-Answer Session
Larry Biegelsen
Wells Fargo Securities, LLC, Research Division
So Jay, let’s just start at a high level, just maybe [Technical Difficulty] at GE HealthCare.
James Saccaro
VP & CFO
So Larry, reflecting on that yesterday, and this is the third year that we’ve been at the conference since we became an independent company. And I have to say we are incredibly proud of the progress that we’ve made. Price standpoint, most notably, we substantially increased investment in R&D over the last several years and we have advanced products through the pipeline to the point where we’re sitting on a series of launches that will take place in 2026 that will, over time, really transform our company. The second thing I would say is we’ve done an incredible job on margin, controllable margin. We really have focused on implementing
